Association between level of compliance with COVID-19 public health measures and depressive symptoms: A cross-sectional survey of young adults in Canada and France.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 08 10 2022
accepted: 20 07 2023
medline: 4 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

While compliance with preventive measures remains central to limit the spread of COVID-19, these measures critically affected mental health of young adults. We therefore investigated the association between the level of compliance with COVID-19 preventive measures and depressive symptoms among young adults in Canada and France. From October to December 2020, we conducted a cross-sectional online survey of young adults ages 18-29 years in Canada (n = 3246) and France (n = 2680) to collect demographic data, experiences with COVID-19 preventive measures, and mental health. Depressive symptoms were assessed by the Patient Health Questionnaire-9 (PHQ-9). Compliance profiles were built using cluster analysis. Weighted multivariable logistic regression was used to estimate associations between compliance level and major depressive symptoms (PHQ-9 score≥15) in each country. One third of respondents reported major depressive symptoms (Canada: 36.4%, France: 23.4%). Four compliance profiles were identified: high (42.5%), medium-high (21.7%), medium-low (18.1%), and low (17.7%), with high levels more frequently observed in Canada compared to France. In both countries, participants in low compliance profile (Canada: Adjusted Odds Ratio (AOR) [95% Confidence Interval] 0.75 [0.58, 0.98], France: AOR 0.60 [0.46, 0.75]), in the medium-low (Canada: AOR 0.58 [0.48, 0.72], France: AOR 0.81 [0.66, 1.01]), and medium-high compliance profiles (Canada: AOR 0.78 [0.65, 0.93], France: AOR 0.77 [0.63, 0.93]) were less likely to report major depressive symptoms compared to the high compliance profile. Ethno-racial minorities, sexual and gender minority, and unemployed young adults had higher odds of reporting such symptoms. Major depressive symptoms were associated with high compliance with COVID-19 preventive measures among young adults. The implementation of socially-isolating measures should be coupled with mental health interventions to address mental health needs of young adults, with enhanced supports for sub-groups who are structurally disadvantaged (e.g., racialized, unemployed, sexual and gender minority).

Sections du résumé

BACKGROUND
While compliance with preventive measures remains central to limit the spread of COVID-19, these measures critically affected mental health of young adults. We therefore investigated the association between the level of compliance with COVID-19 preventive measures and depressive symptoms among young adults in Canada and France.
METHODS
From October to December 2020, we conducted a cross-sectional online survey of young adults ages 18-29 years in Canada (n = 3246) and France (n = 2680) to collect demographic data, experiences with COVID-19 preventive measures, and mental health. Depressive symptoms were assessed by the Patient Health Questionnaire-9 (PHQ-9). Compliance profiles were built using cluster analysis. Weighted multivariable logistic regression was used to estimate associations between compliance level and major depressive symptoms (PHQ-9 score≥15) in each country.
RESULTS
One third of respondents reported major depressive symptoms (Canada: 36.4%, France: 23.4%). Four compliance profiles were identified: high (42.5%), medium-high (21.7%), medium-low (18.1%), and low (17.7%), with high levels more frequently observed in Canada compared to France. In both countries, participants in low compliance profile (Canada: Adjusted Odds Ratio (AOR) [95% Confidence Interval] 0.75 [0.58, 0.98], France: AOR 0.60 [0.46, 0.75]), in the medium-low (Canada: AOR 0.58 [0.48, 0.72], France: AOR 0.81 [0.66, 1.01]), and medium-high compliance profiles (Canada: AOR 0.78 [0.65, 0.93], France: AOR 0.77 [0.63, 0.93]) were less likely to report major depressive symptoms compared to the high compliance profile. Ethno-racial minorities, sexual and gender minority, and unemployed young adults had higher odds of reporting such symptoms.
CONCLUSIONS
Major depressive symptoms were associated with high compliance with COVID-19 preventive measures among young adults. The implementation of socially-isolating measures should be coupled with mental health interventions to address mental health needs of young adults, with enhanced supports for sub-groups who are structurally disadvantaged (e.g., racialized, unemployed, sexual and gender minority).

Identifiants

pubmed: 37531389
doi: 10.1371/journal.pone.0289547
pii: PONE-D-22-27847
pmc: PMC10395933
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289547

Subventions

Organisme : CIHR
ID : VR5 172673
Pays : Canada
Organisme : CIHR
ID : AWD-017639
Pays : Canada
Organisme : CIHR
ID : MFE – 176609
Pays : Canada

Informations de copyright

Copyright: © 2023 Coulaud et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2021 Jan 7;16(1):e0245327
pubmed: 33411812
Psychol Med. 2022 Oct;52(13):2549-2558
pubmed: 33183370
BMC Fam Pract. 2015 May 08;16:57
pubmed: 25951898
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Global Health. 2021 Mar 22;17(1):29
pubmed: 33752717
BMC Public Health. 2021 Jul 13;21(1):1385
pubmed: 34256717
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychiatry Res. 2021 Feb;296:113648
pubmed: 33348199
JAMA Netw Open. 2020 Oct 1;3(10):e2025591
pubmed: 33095252
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
J Med Internet Res. 2020 Sep 3;22(9):e21279
pubmed: 32805704
Cognit Ther Res. 2020;44(6):1043-1051
pubmed: 32904454
Nat Hum Behav. 2020 May;4(5):460-471
pubmed: 32355299
PLoS One. 2020 Jul 23;15(7):e0236337
pubmed: 32702065
Int J Environ Res Public Health. 2021 Mar 21;18(6):
pubmed: 33801095
J Youth Adolesc. 2021 Jan;50(1):44-57
pubmed: 33108542
Psychiatry Res. 2020 Aug;290:113172
pubmed: 32512357
Can J Public Health. 2022 Jun;113(3):394-404
pubmed: 35437697
Soc Sci Med. 2021 Jan;268:113370
pubmed: 32980677
Am J Public Health. 2021 Sep;111(9):1610-1619
pubmed: 34410817
Am J Public Health. 2021 Mar;111(3):384-386
pubmed: 33566642
Am J Public Health. 2022 Mar;112(3):453-466
pubmed: 35196054
BMC Public Health. 2021 Jan 18;21(1):152
pubmed: 33461508
Pediatrics. 2021 Sep;148(3):
pubmed: 34140393
JAMA. 2020 May 19;323(19):1908-1909
pubmed: 32275299
Psychiatry Res. 2021 Jan;295:113631
pubmed: 33310417
PLoS One. 2020 Oct 7;15(10):e0239795
pubmed: 33027281
Prev Med. 2021 Apr;145:106333
pubmed: 33509605
Am J Infect Control. 2021 Aug;49(8):1036-1042
pubmed: 33577824
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
PLoS One. 2012;7(12):e52028
pubmed: 23251676
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Vaccine. 2022 Apr 6;40(16):2442-2456
pubmed: 35305823
Int J Environ Res Public Health. 2020 Jul 08;17(14):
pubmed: 32650522
J Clin Epidemiol. 2020 Jun;122:115-128.e1
pubmed: 32105798
BMC Public Health. 2022 Feb 21;22(1):369
pubmed: 35189862
Int J Environ Res Public Health. 2020 Sep 14;17(18):
pubmed: 32937929
Psychiatry Res. 2020 Nov;293:113419
pubmed: 32861098
BMJ Open. 2021 Jun 25;11(6):e049405
pubmed: 34172551
Health Commun. 2021 Jan;36(1):32-41
pubmed: 33256466
J Homosex. 2021 Mar 21;68(4):577-591
pubmed: 33399504
Br J Math Stat Psychol. 2006 May;59(Pt 1):1-34
pubmed: 16709277
J Affect Disord. 2020 Dec 1;277:392-393
pubmed: 32861840
Prev Med. 2021 Dec;153:106713
pubmed: 34242662
Prev Med Rep. 2020 Nov 25;21:101252
pubmed: 33364149
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334399
PLoS One. 2021 Mar 5;16(3):e0247999
pubmed: 33667243
Nat Med. 2021 Jun;27(6):993-998
pubmed: 33864052
J Community Health. 2021 Aug;46(4):758-766
pubmed: 33165765
Int J Environ Res Public Health. 2020 Sep 01;17(17):
pubmed: 32882922
J Homosex. 2021 Mar 21;68(4):592-611
pubmed: 33502286
Br J Psychiatry. 2021 Jun;218(6):326-333
pubmed: 33081860
Psychiatry Res. 2020 Nov;293:113486
pubmed: 33007682
Prev Sci. 2021 Nov;22(8):1013-1022
pubmed: 34275054
BMC Psychol. 2021 Jun 8;9(1):95
pubmed: 34103081
Psychiatry Res. 2020 Nov;293:113462
pubmed: 32987222
J Law Med Ethics. 2015 Spring;43(1):116-33
pubmed: 25846043
Prev Sci. 2009 Jun;10(2):87-99
pubmed: 19003535
BMC Public Health. 2021 Mar 15;21(1):503
pubmed: 33722226

Auteurs

Pierre-Julien Coulaud (PJ)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Julie Jesson (J)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.

Naseeb Bolduc (N)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Olivier Ferlatte (O)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Département de Médecine Sociale et Préventive, École de Santé Publique de l'Université de Montréal, Montréal, Québec, Canada.
Centre de Recherche en Santé Publique, Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.

Karine Bertrand (K)

Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Longueuil, Québec, Canada.

Travis Salway (T)

Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Centre for Gender and Sexual Health Equity, Vancouver, British Columbia, Canada.

Marie Jauffret-Roustide (M)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Centre d'Étude des Mouvements Sociaux (EHESS/CNRS UMR8044/INSERM U1276), Paris, France.
Baldy Center on Law and Social Policy, Buffalo University, Buffalo, NY, United States of America.

Rod Knight (R)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Département de Médecine Sociale et Préventive, École de Santé Publique de l'Université de Montréal, Montréal, Québec, Canada.
Centre de Recherche en Santé Publique, Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH